ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 72 filers reported holding ATHIRA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $41,025 | -19.5% | 16,410 | +2.0% | 0.00% | – |
| Q4 2022 | $50,983 | +6.2% | 16,083 | -0.4% | 0.00% | – |
| Q3 2022 | $48,000 | -2.0% | 16,141 | +1.4% | 0.00% | – |
| Q2 2022 | $49,000 | -77.3% | 15,913 | -0.6% | 0.00% | -100.0% |
| Q1 2022 | $216,000 | -3.1% | 16,012 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $223,000 | +34.3% | 17,139 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $166,000 | -10.3% | 17,652 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $185,000 | +24.2% | 18,072 | +123.4% | 0.00% | 0.0% |
| Q1 2021 | $149,000 | -41.8% | 8,089 | +8.3% | 0.00% | 0.0% |
| Q4 2020 | $256,000 | – | 7,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |